GeparSixto: Neoadjuvant Chemotherapy ± Carboplatin in Patients With HER2-Positive or Triple-Negative Early Breast Cancer

Slideset - Adding carboplatin to neoadjuvant chemotherapy significantly improved DFS in triple-negative but not HER2+ early breast cancer.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research